Javascript must be enabled to continue!
FORMULATION, ANALYSIS AND VALIDATION OF NANOSUSPENSIONS-LOADED VORICONAZOLE TO ENHANCE SOLUBILITY
View through CrossRef
Objective: This study aimed to enhance the solubility of voriconazole (VRZ) via loading to nanosuspensions using solvent/anti-solvent technique. The optimisation of independent variables (polymer concentrations) was carried out to achieve the desired particle size and maximise the percentage of entrapment efficiency (EE %) and drug loading (DL %) using design-expert®software.
Methods: Design-Expert® software, version 13, was used to design and optimise nanosuspensions-loaded VRZ using 23 factorial designs. Concentrations of polyvinylpyrrolidone, hydroxypropyl methylcellulose and poloxamers were selected as independent variables to achieve ideal particle size, polydispersity index (PDI), entrapment efficacy (EE %) and drug loading (DL %). Atomic force microscopy (AFM), differential scanning calorimetry (DSC) and saturated solubility were used to assess the lyophilized nanoparticles. The compatibility between the drug and the polymers was studied using Fourier transform infrared spectroscopy (FTIR).
Results: The particle size, PDI, EE %, and DL % were in the range of 15.6–145.6 nm, 0.010-0.120, 55.9 %-91.9 %, and 6.68-36.76 %, respectively. The saturated solubility of nanosuspensions-loaded VRZ (NS-VRZ) relative to free VRZ was increased tenfold in DW and twelvefold in PBS (pH 7.4). DSC thermogram confirmed the incorporation of VRZ in the nanosuspensions. The AFM of NS-VRZ validated spherical tiny particle size with a smooth surface. There is no chemical interaction between VRZ and the polymers, according to an FTIR investigation.
Conclusion: The solubility of VRZ was successfully enhanced by loading to nanosuspensions. The solvent/anti-solvent technique was proven to be cost-effective, easy to operate and suitable for the preparation of NS-VRZ using Design-Expert®software.
Innovare Academic Sciences Pvt Ltd
Title: FORMULATION, ANALYSIS AND VALIDATION OF NANOSUSPENSIONS-LOADED VORICONAZOLE TO ENHANCE SOLUBILITY
Description:
Objective: This study aimed to enhance the solubility of voriconazole (VRZ) via loading to nanosuspensions using solvent/anti-solvent technique.
The optimisation of independent variables (polymer concentrations) was carried out to achieve the desired particle size and maximise the percentage of entrapment efficiency (EE %) and drug loading (DL %) using design-expert®software.
Methods: Design-Expert® software, version 13, was used to design and optimise nanosuspensions-loaded VRZ using 23 factorial designs.
Concentrations of polyvinylpyrrolidone, hydroxypropyl methylcellulose and poloxamers were selected as independent variables to achieve ideal particle size, polydispersity index (PDI), entrapment efficacy (EE %) and drug loading (DL %).
Atomic force microscopy (AFM), differential scanning calorimetry (DSC) and saturated solubility were used to assess the lyophilized nanoparticles.
The compatibility between the drug and the polymers was studied using Fourier transform infrared spectroscopy (FTIR).
Results: The particle size, PDI, EE %, and DL % were in the range of 15.
6–145.
6 nm, 0.
010-0.
120, 55.
9 %-91.
9 %, and 6.
68-36.
76 %, respectively.
The saturated solubility of nanosuspensions-loaded VRZ (NS-VRZ) relative to free VRZ was increased tenfold in DW and twelvefold in PBS (pH 7.
4).
DSC thermogram confirmed the incorporation of VRZ in the nanosuspensions.
The AFM of NS-VRZ validated spherical tiny particle size with a smooth surface.
There is no chemical interaction between VRZ and the polymers, according to an FTIR investigation.
Conclusion: The solubility of VRZ was successfully enhanced by loading to nanosuspensions.
The solvent/anti-solvent technique was proven to be cost-effective, easy to operate and suitable for the preparation of NS-VRZ using Design-Expert®software.
Related Results
A reappraisal of measured voriconazole concentration based on plasma albumin concentration during therapeutic drug monitoring
A reappraisal of measured voriconazole concentration based on plasma albumin concentration during therapeutic drug monitoring
Background: The unbound fraction of voriconazole can be elevated due to a decreased plasma albumin concentration. Given its nonlinear pharmacokinetic profile, this elevation can ca...
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Effects of inflammation on voriconazole metabolism and peripheral blood trough concentration
Abstract
Background
The inner association of inflammation with voriconazole (VCZ) metabolism has not been fully investigated. This study further discussed the relationship...
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Efavirenz 400 mg q24 h reduces exposure to voriconazole 200 mg q12 h when the two drugs are co‐administered.• Furthermore, voriconazole i...
Preserving hesperetin nanosuspensions for dermal application
Preserving hesperetin nanosuspensions for dermal application
Nanosuspensions as aqueous formulations need to be preserved. However, preservatives could vitiate the physical stability of suspensions and to a greater extent nanosuspensions. Th...
In vivo evaluation of voriconazole eye drops efficacy in a rat Acanthamoeba polyphaga keratitis model
In vivo evaluation of voriconazole eye drops efficacy in a rat Acanthamoeba polyphaga keratitis model
PurposeAcanthamoeba keratitis is a sight‐threatening infectious disease. Its effective and safe medical therapy remains highly debated. The aim of this study is to test in vitro an...
Surface Solid Dispersion Technique for Solubility Enhancement of Nifedipine
Surface Solid Dispersion Technique for Solubility Enhancement of Nifedipine
Introduction:
Poor solubility is a common challenge in pharmaceuticals, hindering oral bioavailability. High throughput screening has led to an increase in
poor...
Formulation and evaluation of Flupirtine N-[2-amino-6-[(4-fluorophenyl)methylamino]-3- pyridinyl]carbamic acid ethyl ester nanosuspension by precipitation method
Formulation and evaluation of Flupirtine N-[2-amino-6-[(4-fluorophenyl)methylamino]-3- pyridinyl]carbamic acid ethyl ester nanosuspension by precipitation method
Flupirtine N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester nanosuspensions were prepared by precipitation method to accelerate the rate of dissolut...
INTERNATIONAL MULTICENTER EXPERIENCE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED CANCER PATIENTS
INTERNATIONAL MULTICENTER EXPERIENCE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED CANCER PATIENTS
BACKGROUND: Invasive aspergillosis (IA) is a life-threatening infection in immunocompromised patients. In this study, we compared the efficacy of voriconazole containing regimen vs...

